Canadian researchers assessed whether exposure to wildfire-related fine particulate matter was associated with ED visits for migraine and other headaches.
In this interview, Arwen Podesta, MD, DFAPA, DFASAM, describes how alcohol use disorder remains a significant burden for patients and the health care system, and that clinicians across specialties should...
An updated evidence-based practice guideline published in Headache outlines when to initiate pharmacologic migraine prevention in adults and how to select, assess, and discontinue treatment.
Pediatric safety and pharmacokinetic findings supported expanding leniolisib to children aged 4 to 11 years who weigh at least 27 kg, establishing the first FDA-approved treatment for activated...
A multisite surveillance study published in Pediatrics assessed trends and determinants of influenza antiviral use in hospitalized children across the United States before and during the late COVID-19...
Results from the SOHO-01 trial supported expanded use of sevabertinib in adults with HER2-mutated, locally advanced or metastatic nonsquamous non–small cell lung cancer, including patients who had not...
